Cargando…
Experimental model proposed to deduce pharmacological evidence of the beta-cell neogenesis activity of Argyrolobium roseum vis-a-vis an evaluation of its hypoglycemic activity
BACKGROUND: Argyrolobium roseum is described in texts for its botanical aspects with no mention of its therapeutic uses. Recently, a solvent fraction of this plant has been reported to possess insulin secretagogue activity. OBJECTIVE: Primary objective of the study was to evaluate the hypoglycemic a...
Autores principales: | Gupta, OP, Malhotra, Pavan, Kudyar, Surbhi, Singh, Aneeta, Gupta, Geetika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657975/ https://www.ncbi.nlm.nih.gov/pubmed/23776786 http://dx.doi.org/10.4103/2229-516X.91153 |
Ejemplares similares
-
Pharmacological effect of Argyrolobium roseum (Camb.) Jaub & Spach extracts against lead‐induced toxicity in rats
por: Rasool, Naeem, et al.
Publicado: (2023) -
Sodium glucose co-transporter inhibitors – A new class of old drugs
por: Malhotra, Aneeta, et al.
Publicado: (2015) -
The Pathogenesis of Adenomyosis vis-à-vis Endometriosis
por: Guo, Sun-Wei
Publicado: (2020) -
Citicoline and COVID-19: vis-à-vis conjectured
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
Vis Conservatrix
por: Payne, F. R.
Publicado: (1867)